|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | 冠状动脉钙化在高血压患者心血管病风险分层中的作用显示文摘研究者研究了冠状动脉钙化(coronary artery calcium,CAC)在成人高血压心血管病风险分层中的作用,包括符合收缩压干预试验(systolic blood pressure intervention trial,SPRINT)标准的患者。此外,研究者使用CAC来确定心血管病死亡率与SPRINT中标准降压组心血管病死亡率('SPRINT水平')相当的高血压成年患者,其可能受益于强化降压治疗。研究人群包括来自CAC研究联盟的高血压患者16 167例,其中6375例患者构成'SPRINT类似人群'。研究者按CAC分类(0,1~99,100~399,≥400)比较了多因素校正后的冠状动脉粥样硬化性心脏病(冠心病)和心血管病死亡风险比。 | 刘青(译) 叶鹏(摘、审校) Uddin SMI Mirbolouk M Kianoush S Orimoloye OA Dardari Z Whelton SP Miedema MD Nasir K Rumberger JA Shaw LJ Berman DS Budoff MJ McEvoy JW Matsushita K Blaha MJ Graham G | 2019 | 中华高血压杂志2019，27，5： | 3 |
| 2 | Multiple facets of NF-κB in the heart:to be or not to NF-κB显示文摘 | Gordon JW Shaw JA Kirshenbaum LA | | 0，，09： | 1 |
| 3 | Potent and persis- tent in vivo anti - HBV activity of chemically modified siR- NAs显示文摘 | Morrissey DV Lockridge JA Shaw L | 2005 | Nat Biotechnol2005，23，8： | 1 |
| 4 | Genomic analysis of circulat- ing cell-free DNA infers breast cancer dormancy 显示文摘 | Shaw JA Page K Blighe K | 2012 | Genome Res2012，22，2： | 1 |
| 5 | Oestrogen receptors alpha and beta differ in normal human breast and breast careinomas显示文摘 | Shaw JA Udokang K Mosquera JM | 2002 | J Pathol2002，198，4： | 1 |
| 6 | Potent and persistent in vivo anti-HBV activity of chemically modified siRNAs 显示文摘 | Morrissey DV Lockridge JA Shaw L | 2005 | Nat Biotechnol2005，23，8： | 1 |
| 7 | Community pharmacists perspectives on pharmaceutical care implementation in New Zealand显示文摘 | Dunlop JA Shaw JP | 2002 | Pharm World Sci2002，24，： | 1 |
| 8 | MR imaging and histologic features of capillary telangiectasia of the basal ganglia显示文摘 | Gastillo M Morrison T Shaw JA | 2001 | AJNR2001，22，8： | 1 |
| 9 | Changes in subtypes of Ca microdomains following partial injury to the central nervous system显示文摘 | Lozic I Bartlett CA Shaw JA Iyer KS Dunlop SA Kilburn MR Fitz-gerald M | | 0，，： | 1 |
| 10 | MHC class II expression by microglia in tetanus toxininduced experimental epilepsy in the rat 显示文摘 | Perry VH Mellanby J | 1994 | Neuropathol Appl Neurobiol1994，20，4： | 1 |
| 11 | Genomic analysis ofcirculating cell-free DNA infers breast cancer dormancy显示文摘 | SHAW JA PAGE K BLIGHE K | 2012 | Ge-nome Res2012，22，2： | 1 |
| 12 | Renal impairment is an independent predictor of adverse events post coronary intervention in patients with and without drug-eluting stents显示文摘 | Shaw JA Andrianopoulos N Duffy S | 2008 | Cardiovasc Revasc Med2008，9，4： | 1 |
| 13 | Clinical ac- tivity of crizotinib in advanced non-small cell lung cancer (NSCLC) harboring ROS1 gene rearrangement 显示文摘 | Shaw AT Camidge DR Engelman JA | 2012 | J Clin 0ucol2012，，： | 1 |
| 14 | Sporadic breast cancer in young women:prevalence of loss heterozygosity at P53,BRCA1 and BRCA2显示文摘 | Johnson SM Shaw JA Walker RA | 2002 | Int J Cancer2002，98，2： | 1 |
| 15 | Pancreas transplantation显示文摘 | White SA Shaw JA Sutherland DE | 2009 | Lancet2009，373，9677： | 1 |
| 16 | Emergency relief system designusing DIERS technology 显示文摘 | Fisher H G Forrest H S Grossel S S HuffJ E Muller A R Noronha JA Shaw D A Tilley B J | 1992 | 1992，，： | 1 |
| 17 | Glomerular expression of nephrin is decreased in acquired human nephrotic syndrome 显示文摘 | Furness PN Hall LL Shaw JA | 1999 | Nephrol Dial Transplant1999，14，5： | 1 |
| 18 | Clinical activity of cr- izotinib in advanced non-small cell lung cancer(NSCLC) harboring ROS1 gene rearrangement显示文摘 | Shaw AT Camidge DR Engelman JA | 2012 | J Clin Oncol2012，30，： | 1 |
| 19 | Genomic analysis of circulating cell-free DNA infers breast cancer dor- mancy 显示文摘 | Shaw JA Page K Blighe K | 2012 | Genome Res2012，22，2： | 1 |
| 20 | Long-ter fol- low-up of a randomized controlled trim comparing accep- tance and commitment therapy and standard cognitive behav- ior therapy for anxiety and depression 显示文摘 | Forman EM Shaw JA Goetter EM | 2012 | Behavior Therapy2012，43，4： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员